BNP PARIBAS FINANCIAL MARKETS - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 160 filers reported holding CARDLYTICS INC in Q1 2022. The put-call ratio across all filers is 3.56 and the average weighting 0.7%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$434,016
+674.9%
26,304
+196.8%
0.00%
Q2 2023$56,008
-25.7%
8,862
-60.1%
0.00%
Q1 2023$75,369
-69.4%
22,200
-48.0%
0.00%
Q4 2022$246,586
-99.8%
42,662
+165.4%
0.00%
Q3 2022$151,077,000
-31.2%
16,072
+63.4%
0.00%
Q2 2022$219,486,000
+42.0%
9,838
+249.9%
0.00%
Q1 2022$154,604,000
-66.0%
2,812
-59.1%
0.00%
-100.0%
Q4 2021$454,567,000
-10.3%
6,878
+13.9%
0.00%0.0%
Q3 2021$506,914,000
+240.2%
6,039
+414.4%
0.00%
Q2 2021$149,016,000
-64.8%
1,174
-69.5%
0.00%
-100.0%
Q1 2021$422,784,000
-39.9%
3,854
-21.7%
0.00%0.0%
Q4 2020$702,999,000
+61.0%
4,924
-20.4%
0.00%0.0%
Q3 2020$436,758,000
+482.2%
6,189
+477.3%
0.00%
Q2 2020$75,019,000
-51.6%
1,072
-75.8%
0.00%
Q1 2020$155,118,000
-98.5%
4,437
-97.2%
0.00%
-100.0%
Q4 2019$10,142,147,000
+15667.0%
161,345
+8307.8%
0.02%
Q3 2019$64,325,000
+267.3%
1,919
+184.7%
0.00%
Q2 2019$17,511,000
-16.5%
674
-46.8%
0.00%
Q1 2019$20,973,000
+2051.1%
1,268
+1308.9%
0.00%
Q4 2018$975,000
-78.2%
90
-49.7%
0.00%
Q3 2018$4,482,000
-6.8%
179
-19.0%
0.00%
Q2 2018$4,809,000
-64.9%
221
-76.4%
0.00%
Q1 2018$13,708,0009370.00%
Other shareholders
CARDLYTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders